175
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Effect of shark cartilage derived protein on the NK cells activity

, , , , &
Pages 403-409 | Received 03 May 2010, Accepted 08 Jun 2010, Published online: 29 Jul 2010

References

  • Lee, A., Langer, R. Shark cartilage contains inhibitors of tumor angiogenesis. Science 1983, 221, 1185–1187.
  • Castronove, V., Dimitriadou, V., Savard, P., Rivie`re, M., Dupont, E. Cartilage as a source of natural inhibitors of angiogenesis. In: Teicher, B.A., ed. Angiogenic Agents in Cancer Therapy. Totowa, NJ: Humana Press Inc, 1999; 175–183.
  • Fontenele, J.B., Araújo, G.B., de Alencar, J.W., Viana, G.S. The analgesic and anti-inflammatory effects of shark cartilage are due to a peptide molecule and are nitric oxide (NO) system dependent. Biol. Pharm. Bull. 1997, 20, 1151–1154.
  • Gomes, E.M., Souto, P.R.F., Felzenswalb, I. Shark cartilage containing preparation protects cells against hydrogen peroxide induced and mutagenesis. Mutat. Res. 1996, 367, 203–208.
  • Lane, J.W. Method and dosage unit for inhibiting angiogenesis or vascularization in animal using shark cartilage. United. States. Patent. 1991; USP No: 5,075,112.
  • Matheews, J. Media feeds frenzy over shark cartilage as cancer treatment. J. Natl. Cancer. Inst. 1993, 85, 1190–1191.
  • Hunt, T.J., Connelly, J.F. Shark cartilage for cancer treatment. Am. J. Health. Syst. Pharm. 1995, 52, 1756–1760.
  • Green, S. Shark cartilage therapy against cancer. Nutr. Health. Forum. 1997, 14, 1–5.
  • Raithaus, L.R. Shark liver for stimulating the immune system. United. States. Patent. 1998, USP No: 5,840,342.
  • Feyzi, R., Hassan, Z.M., Mostafaie, A. Modulation of CD(4)(+) and CD(8)(+) tumor infiltrating lymphocytes by a fraction isolated from shark cartilage: shark cartilage modulates anti-tumor immunity. Int. Immunopharmacol. 2003, 3, 921–926.
  • Gorski, A., Kupiec-Weglinski, J.W. Extracellular matrix proteins, regulators of T-cell functions in healthy and diseased individuals. Clin. Diagn. Lab. Immunol. 1995, 2, 646–651.
  • Gilat, D., Cahalon, L., Hershkoviz, R., Lider, O. Interplay of T-cells and cytokines in the context of enzymatically modified extracellular matrix. Immunol. Today. 1996, 17, 16–20.
  • Sosnowska, D., Mysliwski, A., Dzierzbicka, K., Kolodziejczyk, A.M. The in vitro effect of new muramyl peptide derivatives on cytotoxic activity of NK (natural killer) cells from hamsters bearing Ab Bomirski melanoma. Biotherapy 1997, 10, 161–168.
  • Garcia-Penarrubia, P., Cabrera, L., Alvarez, R., Galvez J. Effector-Target interactions: saturability, affinity and binding isotherms. A study of such interactions in the human NK cell—K562 tumour cell system. J. Immunol. Methods. 1992, 155, 133–147.
  • Rosenberg, S.A. Immunotherapy of cancer using interleukin 2: current status and future prospects. Immunol. Today. 1988, 9, 58–62.
  • Sedlacek, H. H., Weidman, E., Seiler, F.R. Tumor immunotherapy using vibrocholerae neuraminidase(VCN). In: Jeljaszewicz, J., Pulverer, G., eds. Bacteria and Cancer. London, UK: Academic Press, 1982; pp. 246–290.
  • Bigda, J., Mysliwska, A., Mysliwska, J., Witkowski, J., Kmiec, Z., Bomirski, A. Natural killer sensitivity of four Bomirski melanoma variants. Cancer Lett. 1989, 44, 67–72.
  • Bigda, J., Mysliwski, A., Sosnowska, D., Romanowski, P., Bomirski, A. Natural killer sensitivity of tumor cells isolated from primary and metastatic lesions of four Bomirski melanoma variants. Clin. Exp. Metastasis 1991, 9, 57–65.
  • Korzeniewski, C., Callewaert, D.M. An enzyme-release assay for natural cytotoxicity. J. Immunol. Methods 1983, 64, 313–320.
  • Lemaire, I., St-Jean, M. Modulation of lung-associated natural killer activity by resident and activated alveolar macrophages. Immunol. Invest. 1990, 19, 27–40.
  • Lafuma, C., Moczar, M., Robert, L. Isolation and characterization of lung connective-tissue glycoproteins. Biochem. J. 1982, 203, 593–601.
  • Folch, J., Less, M., Sloane Stanley, H.G. A Simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957, 226, 497–509.
  • Boils, S., Christopher, C., Handley, C. Passive loss of proteoglycan from articular cartilage explants. Biochim. Biophys. Acta. 1989, 993, 157–167.
  • Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248–254.
  • Front, P., Aprile, F., Mitrovic, D.R., Swann, D.A. Age-related changes in the synthesis of matrix macromolecules by bovine articular cartilage. Connect. Tissue Res. 1989, 19, 121–133.
  • Schägger, H., von Jagow, G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 1987, 166, 368–379.
  • Morrissey, J.H. Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal. Biochem. 1981, 117, 307–310.
  • Lui, G., Carrega, P., Ferlazzo, G. Principles of NK Cell/DC crosstalk: the importance of cell dialogue for a protective immune response. Transfusion. Med. Hemotherap. 2006, 33, 50–57.
  • Gross, C., Hansch, D. Interaction of heat shock protein 70 peptide with NK cells involves the NK receptor CD94. Biol. Chem. 2003, 384, 267–279.
  • Kuster, T., Staudenmann, W., Hughes, G.J., Heizmann, C.W. Parvalbumin isoforms in chicken muscle and thymus. Amino acid sequence analysis of muscle parvalbumin by tandem mass spectrometry. Biochemistry 1991, 30, 8812–8816.
  • Brewer, J.M., Wunderlich, J.K., Ragland, W.L. The amino acid sequence of avian thymic hormone, a parvalbumin. Biochimie 1990, 72, 653–660.
  • Rabbani-Chadegani, A., Abdossamadi, S., Bargahi A., Yousef-Masboogh, M. Identification of low-molecular-weight protein (SCP1) from shark cartilage with anti-angiogenesis activity and sequence similarity to parvalbumin. J. Pharm. Biomed. Anal. 2008, 46, 563–567.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.